NASDAQ: DLHCDlh Holdings Corp Stock
$3.68+0.16 (+4.55%)
Updated Apr 21, 2025
DLHC Price
$3.68
Fair Value Price
N/A
Market Cap
$52.94M
52 Week Low
$2.72
52 Week High
$12.23
P/E
8.18x
P/B
0.48x
P/S
0.3x
PEG
24.9x
Dividend Yield
N/A
Revenue
$388.87M
Earnings
$6.36M
Gross Margin
20.2%
Operating Margin
6.1%
Profit Margin
1.6%
Debt to Equity
1.92
Operating Cash Flow
$11M
Beta
0.77
Next Earnings
Apr 29, 2025
Ex-Dividend
N/A
Next Dividend
N/A
DLHC Overview
DLH Holdings Corp. provides technology-enabled business process outsourcing, program management solutions, and public health research and analytics services in the United States. The company offers defense and veterans' health solutions, including healthcare, technology, and logistics solutions to the VA, Defense Health Agency, Tele-medicine and Advanced Technology Research Center, Navy Bureau of Medicine and Surgery, and the Army Medical Research and Material Command. It also provides a range of human services and solutions, which consists of monitoring and evaluation, electronic medical records migration, data collection and management, and nutritional and social health assessments; and IT system architecture design, migration plan, and ongoing maintenance services. In addition, the company offers public health and life sciences services, such as clinical trials, epidemiology studies, and disease prevention; and health promotion to underserved and at-risk communities through development of strategic communication campaigns, research on emerging trends, health informatics analyses, and application of best practices. It primarily serves the federal health services market. The company was formerly known as TeamStaff, Inc. and changed its name to DLH Holdings Corp. in June 2012. DLH Holdings Corp. was incorporated in 1969 and is headquartered in Atlanta, Georgia.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine DLHC's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Business Service
Industry Rating
B
DLHC
Ranked#19 of 33
Ranked#19 of 33
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $6.61 | A | |
| $5.05 | B | |
| $70.67 | B |
Be the first to know about important DLHC news, forecast changes, insider trades & much more!
DLHC News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how DLHC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DLHC ($3.68) is trading above its intrinsic value of $2.50, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DLHC is good value based on its earnings relative to its share price (8.18x), compared to the US market average (27.14x)
P/E vs Market Valuation
DLHC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more DLHC due diligence checks available for Premium users.
Valuation
DLHC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
8.18x
Industry
37.08x
Market
27.14x
DLHC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
DLHC is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
DLHC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.48x
Industry
5x
DLHC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
DLHC price to earnings growth (PEG)
For valuing profitable companies with growth potential
DLHC is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
DLHC's financial health
Profit margin
Revenue
$90.8M
Net Income
$1.1M
Profit Margin
1.2%
DLHC's Earnings (EBIT) of $23.72M... subscribe to Premium to read more.
Interest Coverage Financials
DLHC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$325.0M
Liabilities
$213.6M
Debt to equity
1.92
DLHC's short-term assets ($67.57M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DLHC's long-term liabilities ($148.88M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DLHC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DLHC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$11.5M
Investing
-$552.0k
Financing
$12.2M
DLHC's operating cash flow ($10.76M)... subscribe to Premium to read more.
Debt Coverage Financials
DLHC vs Specialty Business Service Stocks
Dlh Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.